Vimarsana
Biggest News Aggregation in the World

Page 26 - Twist Bioscience News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Twist Bioscience. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Twist Bioscience Today - Breaking & Trending Today

Twist Bioscience (NASDAQ:TWST) Shares Down 6.6% - Vimarsana News

Twist Bioscience (NASDAQ:TWST) Shares Down 6.6%

Twist Bioscience Co. (NASDAQ:TWST – Get Free Report) fell 6.6% on Wednesday . The company traded as low as $19.95 and last traded at $19.95. 542,003 shares were traded during trading, a decline of 57% from the average session volume of 1,264,994 shares. The stock had previously closed at $21.36. Analyst Upgrades and Downgrades A […]

Source: wkrb13.com
Twist Bioscience (NASDAQ:TWST) Shares Up 2.1% - Vimarsana News

Twist Bioscience (NASDAQ:TWST) Shares Up 2.1%

Twist Bioscience Co. (NASDAQ:TWST – Get Free Report) shares were up 2.1% during trading on Friday . The stock traded as high as $19.19 and last traded at $19.02. Approximately 65,105 shares traded hands during mid-day trading, a decline of 95% from the average daily volume of 1,264,028 shares. The stock had previously closed at […]

Source: wkrb13.com
Twist Bioscience (NASDAQ:TWST) Shares Down 6.6% - Vimarsana News

Twist Bioscience (NASDAQ:TWST) Shares Down 6.6%

Twist Bioscience Co. (NASDAQ:TWST – Get Free Report) shares fell 6.6% during mid-day trading on Wednesday . The company traded as low as $19.95 and last traded at $19.95. 542,003 shares were traded during mid-day trading, a decline of 57% from the average session volume of 1,264,994 shares. The stock had previously closed at $21.36. […]

Twist Bioscience (NASDAQ:TWST) Given New $26.00 Price Target at Barclays - Vimarsana News

Twist Bioscience (NASDAQ:TWST) Given New $26.00 Price Target at Barclays

Twist Bioscience (NASDAQ:TWST – Free Report) had its price target boosted by Barclays from $20.00 to $26.00 in a research note released on Monday, MarketBeat.com reports. Barclays currently has an overweight rating on the stock. Several other equities analysts have also recently commented on the stock. The Goldman Sachs Group reduced their price objective on […]

Source: wkrb13.com
Global Synthetic Biology Market to grow by USD 28,253.12 million between 2022 and 2027 | The growing application of synthetic biology drives the market - Vimarsana News

Global Synthetic Biology Market to grow by USD 28,253.12 million between 2022 and 2027 | The growing application of synthetic biology drives the market

/PRNewswire/ -- Technavio, a leading provider of industry news and insights, is pleased to announce its latest report on the Global Synthetic Biology Market....